Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: J Clin Pharm Ther. 2020 Jul 14;45(6):1457–1465. doi: 10.1111/jcpt.13223

TABLE 1.

Demographics and characteristics of kidney transplant recipient population (n = 853)

Characteristics Number (%),
mean ± SD
Age at transplant (mean ± SD) 49.76 ± 14.42
Living donor 534 (62.6)
Simultaneous pancreas-kidney 35 (4.1)
Weight (kg) at transplant (mean ± SD) 81.75 ± 20.56
Male recipient 521 (61.1)
Male donor 419 (49.1)
Ancestry
 European 678 (79.5)
 African 175 (20.5)
Cause of kidney diseasea
 Diabetes 178 (20.9)
 Glomerular disease 243 (28.5)
 Other 156 (18.3)
 Hypertension 100 (11.7)
 Polycystic kidney disease 126 (14.8)
 Unknown 50 (5.9)
Cardiovascular disease prior to transplanta
 Myocardial infarction 45 (5.3)
 Stroke 39 (4.6)
 Hypertension 755 (88.5)
 Congestive heart failure 47 (5.5)
 CAD requiring drug treatment 99 (11.6)
 CAD requiring invasive or surgical procedures 107 (12.5)
 Hyperlipidaemia requiring drug treatment at transplant 429 (50.3)
Diabetes at time of transplant 250 (29.3)
Induction immunosuppression
 Monoclonal antibody 339 (39.7)
 Polyclonal antibody 496 (58.1)
 Combination 18 (2.1)
Calcineurin inhibitor at baseline
 Tacrolimus 776 (91.0)
 Cyclosporine 62 (7.3)
 None 15 (1.8)

Abbreviation: CAD, coronary artery disease.

a

The number of cardiovascular diseases exceeds 100% since some individuals had multiple conditions.